Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      AstraZeneca sells ageing beta-blocker to Recordati for $300 mln

      AstraZeneca sells ageing beta-blocker to Recordati for $300 mln

      Ruby Khatun Khatun23 May 2017 1:23 PM IST
      LONDON: AstraZeneca has sold the European rights to its ageing beta-blocker heart drug Seloken to Italy's Recordati for $300 million, as part of a...
      Causing Pollution: NGT slaps Rs 15 lakh fine on Teva API India

      Causing Pollution: NGT slaps Rs 15 lakh fine on Teva API India

      Ruby Khatun Khatun23 May 2017 1:23 PM IST
      New Delhi: The National Green Tribunal slapped a fine of Rs 15 lakh on a pharmaceutical unit in Uttar Pradesh for discharging untreated effluents in...
      Lupin gets CDSCO approval for anti-allergy drug

      Lupin gets CDSCO approval for anti-allergy drug

      Ruby Khatun Khatun23 May 2017 1:22 PM IST
      New Delhi: Drug firm Lupin said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for Bepotastine tablets used in...
      Celgene MS drug clears key trial, but disability data falls short

      Celgene MS drug clears key trial, but disability data falls short

      Ruby Khatun Khatun23 May 2017 9:07 AM IST
      Celgene Corp's multiple sclerosis drug met the main goal of reducing annualized relapse rate, compared with Biogen Inc's Avonex, in a second...
      Divis Laboratories explosion: One dead and another sustains serious burns

      Divis Laboratories explosion: One dead and another sustains serious burns

      Ruby Khatun Khatun22 May 2017 5:42 PM IST
      Visakhapatnam: In an explosion at the dumping yard of the Divis Laboratories, one worker died and another sustained serious burns while segregating...
      FDA surprise checks, Action on Hospitals for reusing catheters, baloons

      FDA surprise checks, Action on Hospitals for reusing catheters, baloons

      Ruby Khatun Khatun22 May 2017 12:23 PM IST
      Mumbai: In a surprise checks, Maharashtra FDA has found that at least four more hospitals have been reusing and reselling Drug Notified Medical...
      Higher rate of heart problems seen with Amgen bone drug in trial

      Higher rate of heart problems seen with Amgen bone drug in trial

      Ruby Khatun Khatun22 May 2017 12:17 PM IST
      Amgen Inc and UCB SA said on Sunday they did not expect their experimental osteoporosis drug to win U.S. approval this year after a higher rate of...
      Natco Pharma gets green nod for Rs 480 crore expansion project

      Natco Pharma gets green nod for Rs 480 crore expansion project

      Ruby Khatun Khatun22 May 2017 12:03 PM IST
      New Delhi: Natco Pharma has received environment clearance (EC) for its Rs 480 crore expansion project in Telangana that would generate 1,500 jobs.The...
      Corporate healthcare revenue to grow 15% this fiscal: Report

      Corporate healthcare revenue to grow 15% this fiscal: Report

      Ruby Khatun Khatun22 May 2017 10:17 AM IST
      MUMBAI: The corporate healthcare sector is expected to clock a stable revenue growth of about 15 per cent this fiscal on account of rise in health...
      India to unveil new drug policy: Officials

      India to unveil new drug policy: Officials

      Ruby Khatun Khatun22 May 2017 9:17 AM IST
      WASHINGTON: India is expected to roll out a new drug policy and devise rules for clinical trials that may bring new projects to the country, a top...
      Alibaba injects 488 million dollar health food assets into Ali Health

      Alibaba injects 488 million dollar health food assets into Ali Health

      Ruby Khatun Khatun21 May 2017 1:41 PM IST
      Alibaba Health Information Technology Ltd said on Friday controlling shareholder Alibaba Group Holding Ltd would sell HK$3.8 billion ($488.3 million)...
      Abbott India Q4 net dips 29 per cent to Rs 42 crore

      Abbott India Q4 net dips 29 per cent to Rs 42 crore

      Ruby Khatun Khatun21 May 2017 10:40 AM IST
      New Delhi: Pharma firm Abbott India on Friday reported a 28.69 per cent plunge in standalone net profit to Rs 42.06 crore for the fourth quarter ended...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok